Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Cerilliant
UBS
Daiichi Sankyo
McKinsey
Citi
Argus Health
QuintilesIMS
Dow
McKesson

Generated: January 20, 2018

DrugPatentWatch Database Preview

NOVOLIN L Drug Profile

« Back to Dashboard

Which patents cover Novolin L, and what generic alternatives are available?

Novolin L is a drug marketed by Novo Nordisk Inc and is included in two NDAs.

The generic ingredient in NOVOLIN L is insulin zinc susp recombinant human. There are thirty-nine drug master file entries for this compound. Additional details are available on the insulin zinc susp recombinant human profile page.
Summary for NOVOLIN L
US Patents:0
Applicants:1
NDAs:2
Clinical Trials: 10
Drug Prices:see details
DailyMed Link:NOVOLIN L at DailyMed
Drug patent expirations by year for NOVOLIN L

US Patents and Regulatory Information for NOVOLIN L

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novo Nordisk Inc NOVOLIN L insulin zinc susp semisynthetic purified human INJECTABLE;INJECTION 018777-001 Aug 30, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Novo Nordisk Inc NOVOLIN L insulin zinc susp recombinant human INJECTABLE;INJECTION 019965-001 Jun 25, 1991 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Harvard Business School
Teva
Colorcon
UBS
Deloitte
Merck
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot